| Accession |
PRJCA011275 |
| Title |
Response to pyrotinib in a patient with metastatic bladder urothelial carcinoma harboring HER2 V842I mutation: a case report |
| Relevance |
Medical |
| Data types |
Whole genome sequencing
|
| Organisms |
Homo
|
| Description |
This is the first reported case of HER2 V842I mutation successfully treated with pyrotinib in BUC, suggesting pyrotinib therapy might serve as a therapeutic option for BUC patients harboring HER2 activating mutation. |
| Sample scope |
Monoisolate |
| Release date |
2024-08-16 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| No funding support
|
|
|
|
|
|
| Submitter |
Tianshu
Liu (liutianshu1969@126.com)
|
| Organization |
Zhongshan Hospital, Fudan University |
| Submission date |
2022-08-18 |
